The Texas Medical Board (TMB) is trying to head off confusion about the new PMP rules before they take effect on March 1, 2020.
On that date, Texas physicians will be required to check the Texas Prescription Monitoring Program (PMP) before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol.
The law requiring these PMP checks passed in 2019, and since that time prescribers have been asking how the law applies in an inpatient setting.
The TMB issued guidance on February 10, 2020, stating that checking the PMP is required for inpatient care. Specifically, the TMB guidance states:
“1.) In an emergency setting, the PMP should be checked at the earliest opportunity with medication reconciliation once there is patient stabilization; and
2.) Upon admission into a facility for inpatient care a PMP check and verification must be conducted by the attending physician. Once the PMP check has been validated and documented in the medical record it would be deemed a sufficient check for the duration of the inpatient care until discharge.”
The TMB described a “facility” as “an ambulatory surgical center, emergency department, or for any other inpatient care.”
According to the TMB, “continuous PMP checks during the course of an inpatient stay where the medication dispensed is for immediate use, and not via prescription, is not required.”
However, a PMP check is still required if the physician is “providing a prescription to the ultimate user (such as providing medications to take home upon discharge), as opposed to ordering medication for immediate inpatient care.”
For more information
- A prescriber’s guide to using the PMP — offers guidance for physicians, along with talking points for patients.
- Check the PMP database
- Set up your PMP account
- View the PMP registration manual
- Read the PMP FAQs
- Contact the PMP at email@example.com or call 512-305-8050.
About the AuthorVisit Website More Content by Laura Hale Brockway